Table 5 Demographic and clinical characteristics of the responders and non-responders of IFX with CMV infection
Characteristics | Responders with CMV infection (n = 6) | Non-responders with CMV infection (n = 5) | p value |
|---|---|---|---|
Sex (men/women), n (%) | 4 (66.7)/2 (33.3) | 2 (40.0)/3 (60.0) | 0.38 |
Age (years)* | 50.8 ± 16.2 | 41.4 ± 17.2 | 0.42 |
Disease duration (years)* | 4.5 ± 4.8 | 10.2 ± 9.6 | 0.32 |
Modified Truelove and Witts severity index* | 8.3 ± 1.7 | 12.4 ± 2.2 | 0.02 |
Mayo score (endoscopy)* | 2.8 ± 0.4 | 3.0 ± 0.0 | 0.37 |
Extent of disease | |||
Left-side type, n (%) | 2 (33.3) | 0 (0.0) | 0.15 |
Extensive colitis, n (%) | 4 (66.7) | 5 (100.0) | |
Concomitant medications | |||
Corticoteroids, n (%) | 0 (0.0) | 1 (20.0) | 0.25 |
Azathioprine/Mercaptopurine, n (%) | 3 (50.0) | 2 (40.0) | 0.74 |
Tacrolimus, n (%) | 1 (16.7) | 4 (80.0) | 0.04 |